OverviewSuggest Edit

MannKind Corporation focuses on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes. The Company's lead product candidate, Afrezza, is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. Afrezza is a rapid-acting inhaled insulin therapy indicated to improve glycemic control in adults with diabetes. Taken at the start of a meal using a specially designed inhaler, Afrezza dissolves rapidly upon inhalation to the deep lung and delivers insulin quickly to the bloodstream.

TypePublic
Founded1991
HQWestlake Village, US
Websitemannkindcorp.com
Employee Ratings3.3
Culture scoreA+

Latest Updates

Employees (est.) (Dec 2019)232(+4%)
Job Openings5
Revenue (FY, 2019)$63 M(+127%)
Share Price (May 2020)$1.5 (+12%)

Key People/Management at MannKind Corporation

Kent Kresa

Kent Kresa

Chairman of the Board
Michael Castagna

Michael Castagna

Chief Executive Officer, Director
Ronald Consiglio

Ronald Consiglio

Director
Patrick McCauley

Patrick McCauley

Chief Commercial Officer
Henry L. Nordhoff

Henry L. Nordhoff

Director
Jennifer Grancio

Jennifer Grancio

DIrector
Show more

MannKind Corporation Office Locations

MannKind Corporation has an office in Westlake Village
Westlake Village, US (HQ)
30930 Russell Ranch Rd #301
Show all (1)

MannKind Corporation Financials and Metrics

MannKind Corporation Revenue

Embed Graph
View revenue for all periods
MannKind Corporation's revenue was reported to be $63.04 m in FY, 2019 which is a 126.3% increase from the previous period.
USD

Revenue (Q1, 2020)

16.2m

Gross profit (Q1, 2020)

12.1m

Gross profit margin (Q1, 2020), %

74.4%

Net income (Q1, 2020)

(9.3m)

EBIT (Q1, 2020)

(7.1m)

Market capitalization (22-May-2020)

319.7m

Closing stock price (22-May-2020)

1.5

Cash (31-Mar-2020)

38.9m

EV

293.1m
MannKind Corporation's current market capitalization is $319.7 m.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

174.8m11.7m27.9m63.0m

Revenue growth, %

(93%)137%126%

Cost of goods sold

47.1m17.2m19.4m20.1m

Gross profit

127.7m(5.5m)8.5m43.0m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

3.0m2.2m2.0m3.5m3.9m4.5m17.4m15.0m14.6m16.2m

Cost of goods sold

2.5m5.1m4.6m4.0m5.1m5.3m4.0m4.3m7.1m4.2m

Gross profit

461.0k(2.9m)(2.5m)(543.0k)(1.2m)(834.0k)13.4m10.7m7.5m12.1m

Gross profit Margin, %

15%(135%)(124%)(16%)(31%)(19%)77%71%51%74%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

22.9m43.9m71.2m29.9m

Accounts Receivable

30.9m2.8m4.0m3.5m

Prepaid Expenses

4.4m3.0m2.6m2.9m

Inventories

2.3m2.7m3.6m4.2m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

48.0m43.4m20.1m26.7m26.2m10.4m34.5m8.0m30.2m38.9m

Accounts Receivable

438.0k1.3m1.8m1.6m2.8m2.8m3.8m5.0m4.1m5.0m

Prepaid Expenses

3.5m2.6m3.1m2.4m2.6m3.0m2.4m2.7m3.6m1.9m

Inventories

3.7m3.2m3.1m3.9m3.7m2.8m3.7m4.0m3.7m3.2m
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

125.7m(117.3m)(87.0m)(51.9m)

Depreciation and Amortization

4.2m3.5m2.9m972.0k

Inventories

(2.3m)(3.3m)(3.2m)(558.0k)

Accounts Payable

(12.1m)3.8m(1.6m)(593.0k)
Quarterly
USDY, 2020

EV/EBIT

-41.2 x

EV/CFO

-26.1 x

Financial Leverage

-0.4 x
Show all financial metrics

MannKind Corporation Operating Metrics

FY, 2017FY, 2018FY, 2019

Patents Issued

930 1.02 k

Patents Issued (Afrezza)

530 570 600

Patent Applications

280 240

Patent Applications (Afrezza)

200 160 125
Show all operating metrics

MannKind Corporation Revenue Breakdown

Embed Graph

MannKind Corporation revenue breakdown by business segment: 40.1% from Commercial Product Sales and 59.9% from Collaboration

MannKind Corporation Online and Social Media Presence

Embed Graph

MannKind Corporation Company Culture

  • Overall Culture

    A+

    92/100

  • CEO Rating

    A+

    96/100

  • Compensation

    A+

    92/100

Learn more on Comparably

MannKind Corporation News and Updates

MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results

Conference Call to Begin Today at 9:00 AM ET Conference Call to Begin Today at 9:00 AM ET

MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results

Conference Call to Begin Today at 9:00 AM ET Conference Call to Begin Today at 9:00 AM ET

MannKind Corporation to Present at H.C. Wainwright 21st Annual Global Investment Conference

WESTLAKE VILLAGE, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will …

MannKind Corporation to Hold 2019 Second Quarter Financial Results Conference Call on August 7, 2019

WESTLAKE VILLAGE, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) will release its 2019 second quarter and year-to-date financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on…

MannKind Corporation Reports 2019 First Quarter Financial Results

Conference Call to Begin Today at 9:00 AM ET Conference Call to Begin Today at 9:00 AM ET

MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call

Conference Call to Begin Today at 9:00 AM ET
Show more

MannKind Corporation Blogs

MannKind Corporation to Hold 2019 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2020

WESTLAKE VILLAGE, Calif. , Feb. 18, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2019 fourth quarter and full year financial results and its management will host a conference call to discuss the financial results and corporate updates at 9:00 AM (Eastern Time) on

Brandon Folkes

Brandon Folkes ryan.manuel Tue, 01/21/2020 - 19:12 Brandon Folkes Cantor Fitzgerald

Steven Lichtman

Steven Lichtman ryan.manuel Tue, 01/21/2020 - 16:59 Steven Lichtman Oppenheimer & Co.

Anthony C. Hooper

Anthony C. Hooper ryan.manuel Mon, 01/06/2020 - 13:51 Member of the Audit Committee Anthony C. Hooper Director Anthony C. Hooper has been one of our directors since January 2020. Most recently, Mr. Hooper served as executive vice president of Global Commercial O…

Afrezza® (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month

Afrezza® (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month Content Import Mon, 01/06/2020 - 08:02 Afrezza® (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this m…

Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza® Relative to Insulin Aspart in Type 1 Diabetes

Publication in DIABETICMedicine Now Available Online WESTLAKE VILLAGE, Calif. , Dec. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation  (NASDAQ: MNKD)  announced today that Hypoglycemia is reduced with use of inhaled Technosphere ® Insulin relative to insulin aspart in type 1 diabetes mellitus has
Show more

MannKind Corporation Frequently Asked Questions

  • When was MannKind Corporation founded?

    MannKind Corporation was founded in 1991.

  • Who are MannKind Corporation key executives?

    MannKind Corporation's key executives are Kent Kresa, Michael Castagna and Ronald Consiglio.

  • How many employees does MannKind Corporation have?

    MannKind Corporation has 232 employees.

  • What is MannKind Corporation revenue?

    Latest MannKind Corporation annual revenue is $63 m.

  • What is MannKind Corporation revenue per employee?

    Latest MannKind Corporation revenue per employee is $271.7 k.

  • Who are MannKind Corporation competitors?

    Competitors of MannKind Corporation include Amgen, Assertio Therapeutics and Lexicon Pharmaceuticals.

  • Where is MannKind Corporation headquarters?

    MannKind Corporation headquarters is located at 30930 Russell Ranch Rd #301, Westlake Village.

  • Where are MannKind Corporation offices?

    MannKind Corporation has an office in Westlake Village.

  • How many offices does MannKind Corporation have?

    MannKind Corporation has 1 office.